These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7120076)

  • 1. HPLC analysis of indomethacin and its impurities in capsule and suppository formulations.
    Kwong E; Pillai GK; McErlane KM
    J Pharm Sci; 1982 Jul; 71(7):828-30. PubMed ID: 7120076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impurities in drugs IV: Indomethacin.
    Curran NM; Lovering EG; McErlane KM; Watson JR
    J Pharm Sci; 1980 Feb; 69(2):187-9. PubMed ID: 7359321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of chlordiazepoxide, its hydrochloride and related impurities in pharmaceutical formulations by reversed-phase high-performance liquid chromatography.
    Roberts SE; Delaney MF
    J Chromatogr; 1984 Jan; 283():265-72. PubMed ID: 6707121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous densitometric determination of indomethacin and its degradation products, 4-chlorobenzoic acid and 5-methoxy-2-methyl-3-indoleacetic acid, in pharmaceutical preparations.
    Krzek J; Starek M
    J AOAC Int; 2001; 84(6):1703-7. PubMed ID: 11767134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of HPLC method for determination of indomethacin and its two degradation products in topical gel.
    Nováková L; Matysová L; Havlíková L; Solich P
    J Pharm Biomed Anal; 2005 Apr; 37(5):899-905. PubMed ID: 15862664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversed-phase high-performance liquid chromatographic assay for the determination of potency and impurities in tazadolene succinate bulk drug and capsules.
    Franks TJ; Stodola JD; Walker JS; Tomlinson P; Skiller CJ
    J Chromatogr; 1986 Feb; 353():379-87. PubMed ID: 3700522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of micellar electrokinetic chromatography method for the determination of three defined impurities in indomethacin.
    Riasová P; Doubková D; Pincová L; Jung O; Polášek M; Jáč P
    Electrophoresis; 2018 Oct; 39(20):2550-2557. PubMed ID: 29664166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin--a national survey V: Determination of aspirin and impurities in enteric coated tablets and suppository formulations and in vitro dissolution of enteric coated tablets.
    Kirchhoefer RD; Jefferson E; Flinn PE
    J Pharm Sci; 1982 Sep; 71(9):1049-52. PubMed ID: 7131273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling indomethacin impurities using high-performance liquid chromatography and nuclear magnetic resonance.
    Hess S; Teubert U; Ortwein J; Eger K
    Eur J Pharm Sci; 2001 Dec; 14(4):301-11. PubMed ID: 11684404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation and determination of impurities in paracetamol, codeine and pitophenone in the presence of fenpiverinium in combined suppository dosage form.
    Vojta J; Hanzlík P; Jedlička A; Coufal P
    J Pharm Biomed Anal; 2015 Jan; 102():85-92. PubMed ID: 25255449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversed-phase high-performance liquid chromatography for evaluating the distribution of pharmaceutical substances in suppository base-phosphate buffer system.
    Dimitrova B; Doytchinova I; Zlatkova M
    J Pharm Biomed Anal; 2000 Nov; 23(6):955-64. PubMed ID: 11095296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of plasma drug concentration and bioavailability of indomethacin controlled release capsule by high performance liquid chromatography].
    Zhang D; Zeng J; Bianba-Cangjue ; Jiang X
    Se Pu; 1997 Nov; 15(6):515-7. PubMed ID: 15739336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an acetic acid ester of monoglyceride as a suppository base with unique properties.
    Dash AK; Cudworth GC
    AAPS PharmSciTech; 2001 Jul; 2(3):E13. PubMed ID: 14727872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paired-ion reversed-phase high-pressure liquid chromatographic assay of pentobarbital-pyrilamine suppositories.
    Block JH; Levine HL; Ayres JW
    J Pharm Sci; 1979 May; 68(5):605-8. PubMed ID: 430500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentobarbital absorption from capsules and suppositories in humans.
    Doluisio JT; Smith RB; Chun AH; Dittert LW
    J Pharm Sci; 1978 Nov; 67(11):1586-8. PubMed ID: 712597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of drugs in pharmaceutical dosage forms by X-ray powder diffractometry.
    Phadnis NV; Cavatur RK; Suryanarayanan R
    J Pharm Biomed Anal; 1997 Apr; 15(7):929-43. PubMed ID: 9160259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin--a national survey III: Determination of impurities in bulk aspirin and aspirin formulations by high-pressure liquid chromatography and spectrophotometry.
    Kirchhoefer RD; Reepmeyer JC; Juhl WE
    J Pharm Sci; 1980 May; 69(5):550-3. PubMed ID: 7381741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Simultaneous determination of gallic acid and hesperidin contained in Xiaogu capsule by HPLC].
    Lin FF; Xie WB; Yu J; Xu WG; Niu FL
    Zhongguo Zhong Yao Za Zhi; 2013 May; 38(10):1518-20. PubMed ID: 23947128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification of the impurities in
    Ma X; Jin L; Li Y; Zheng H; Wei Y
    Se Pu; 2018 Mar; 36(3):268-277. PubMed ID: 30136505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro drug liberation and kinetics of sustained release indomethacin suppository.
    Uzunkaya G; Bergişadi N
    Farmaco; 2003 Jul; 58(7):509-12. PubMed ID: 12818689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.